UNITED STATES

 SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (earliest event reported):             November 14, 2007

 

EMRISE CORPORATION

(Exact name of registrant as specified in its charter)

 

 

9485 Haven Avenue, Suite 100

Rancho Cucamonga, California 91730

(Address of principal executive offices) (Zip code)

 

(909) 987-9220

(Registrant’s telephone number, including area code)

 

Not applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o       Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o       Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o       Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o       Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240-13e-4(c))

 

 

Item 3.01                         Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

 

On November 20, 2007, EMRISE Corporation (the “Company”) issued a press release regarding a letter dated November 14, 2007 that the Company received from NYSE Arca Equities, Inc. staff relating to the listing of the Company’s common stock on NYSE Arca. A copy of the press release is attached as Exhibit 99.1 to this Form 8-K and incorporated herein by reference.

 

Item 9.01                         Financial Statements and Exhibits

 

d.      Exhibits:

 

Exhibit No.		Description
99.1		Press release titled “EMRISE Corporation Announces Receipt of NYSE Arca Non-Compliance Letter with Possible 6 Months to Cure” dated November 20, 2007.

 

2

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

	EMRISE CORPORATION
Dated: November 20, 2007	By:	/S/ D. JOHN DONOVAN
		D. John Donovan, Vice President of Finance and
		Administration (principal financial officer)

 

3

 

INDEX TO EXHIBITS ATTACHED TO THIS REPORT

 

Exhibit No.		Description
99.1		Press release titled “EMRISE Corporation Announces Receipt of NYSE Arca Non-Compliance Letter with Possible 6 Months to Cure” dated November 20, 2007.

 

4